We are live on ! Find out more
BSTC

BioSpecifics Technologies Corp.
BSTC

Delisted

BSTC was delisted on the 1st of December, 2020.

Back to rankings

1 hedge funds and large institutions have $204K invested in BioSpecifics Technologies Corp. in 2020 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 112 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 112

99% less funds holding

Funds holding: 113 → 1 (-112)

100% less capital invested

Capital invested by funds: $254M → $204K (-$254M)

Holders
1
Holders Change
-112
Holders Change %
-99.12%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
112
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS AM
UBS AM
Illinois
+$184K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$29.9M
2
BlackRock
BlackRock
New York
-$23.8M
3
RHJA
Rice Hall James & Associates
California
-$19.5M
4
Russell Investments Group
Russell Investments Group
United Kingdom
-$17.5M
5
Vanguard Group
Vanguard Group
Pennsylvania
-$16.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
California State Teachers Retirement System (CalSTRS)
51
California State Teachers Retirement System (CalSTRS)
California
– -$505K -9,554 Closed
State of Wisconsin Investment Board
52
State of Wisconsin Investment Board
Wisconsin
– -$497K -9,400 Closed
ZCM
53
Zebra Capital Management
Connecticut
– -$469K -8,881 Closed
AllianceBernstein
54
AllianceBernstein
Tennessee
– -$460K -8,700 Closed
Two Sigma Advisers
55
Two Sigma Advisers
New York
– -$423K -8,000 Closed
JP Morgan Chase
56
JP Morgan Chase
New York
– -$411K -7,821 Closed
RhumbLine Advisers
57
RhumbLine Advisers
Massachusetts
– -$376K -7,117 Closed
PCM
58
Perritt Capital Management
Illinois
– -$370K -7,000 Closed
State Board of Administration of Florida Retirement System
59
State Board of Administration of Florida Retirement System
Florida
– -$361K -6,836 Closed
TRCT
60
Tower Research Capital (TRC)
New York
– -$350K -6,619 Closed
New York State Common Retirement Fund
61
New York State Common Retirement Fund
New York
– -$349K -6,600 Closed
JIR
62
James Investment Research
Ohio
– -$341K -6,460 Closed
BCM
63
Bridgeway Capital Management
Texas
– -$338K -6,400 Closed
CS
64
Credit Suisse
Switzerland
– -$300K -5,678 Closed
SFI
65
Susquehanna Fundamental Investments
Pennsylvania
– -$299K -5,654 Closed
SI
66
Shaker Investments
Ohio
– -$287K -5,434 Closed
Principal Financial Group
67
Principal Financial Group
Iowa
– -$283K -5,351 Closed
Deutsche Bank
68
Deutsche Bank
Germany
– -$267K -5,047 Closed
Victory Capital Management
69
Victory Capital Management
Texas
– -$221K -4,181 Closed
SAM
70
Shell Asset Management
Netherlands
– -$220K -4,170 Closed
CIBC Private Wealth Group
71
CIBC Private Wealth Group
Georgia
– -$219K -4,141 Closed
CIS
72
Connors Investor Services
Pennsylvania
– -$215K -4,064 Closed
AG
73
Aperio Group
California
– -$210K -3,988 Closed
Manulife (Manufacturers Life Insurance)
74
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$208K -3,935 Closed
AIG
75
American International Group
New York
– -$197K -3,733 Closed
1 2
3
4 5

BSTC Hedge Fund Activity: Q4 2020 in Review

1 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in BioSpecifics Technologies Corp. (BSTC) for Q4 2020, worth a combined $204K — down 100% from $254M a quarter earlier.

Sellers outnumbered buyers: 112 funds closed out of BSTC and 1 opened new positions — a net loss of 111 holders — while 0 trimmed existing stakes and 0 added.

The largest buyer was UBS AM, opening a new position worth an estimated $184K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $29.9M sold.

  • 1 institutional investor held BioSpecifics Technologies Corp. (BSTC) as of Q4 2020, down from 113 in Q3 2020.
  • Funds reported $204K of BioSpecifics Technologies Corp. stock for Q4 2020, down 100% quarter-over-quarter.
  • 1 fund opened new BioSpecifics Technologies Corp. positions in Q4 2020 and 112 closed out, a net change of -111 holders.
  • The largest BioSpecifics Technologies Corp. buyer in Q4 2020 was UBS AM, an estimated $184K added.
  • The largest BioSpecifics Technologies Corp. seller in Q4 2020 was Renaissance Technologies, an estimated $29.9M sold.

Based on aggregated 13F filings for Q4 2020.